Sitagliptin

3 trials 2 recruiting AGastroenterology

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

2 Recruiting

1 Completed trials

3 Sponsors

6 Countries

Phase IV

Phase IV: 3

Indications tested

Type 2 diabetes mellitus 1

Sponsors using this IMP

Eli Lilly & Co. 1 Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospital Clinico De Valencia-INCLIVA 1 Universita Cattolica Del Sacro Cuore 1

All trials

3 total

A Study of Tirzepatide Compared with Intensified Conventional Care in Adult Participants with Type 2 Diabetes (SURPASS-EARLY) Recruiting

2022-501073-40-00 Phase IV 5 countries Eli Lilly & Co.
SGLT-2i, Heart, Improvement of Cardiovascular Autonomic Neuropathy Recruiting

2025-521748-39-00 Phase IV 1 country Universita Cattolica Del Sacro Cuore
Clinical trial to evaluate whether personalized treatment based on genetics improves type 2 diabetes control Ended

2025-520686-46-00 Phase IV 1 country Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospita…

Showing 1–3 of 3 trials

← All drugs A–Z